UA37043A - Method for diagnostics of diabetic nephropathy - Google Patents

Method for diagnostics of diabetic nephropathy

Info

Publication number
UA37043A
UA37043A UA2000031447A UA200031447A UA37043A UA 37043 A UA37043 A UA 37043A UA 2000031447 A UA2000031447 A UA 2000031447A UA 200031447 A UA200031447 A UA 200031447A UA 37043 A UA37043 A UA 37043A
Authority
UA
Ukraine
Prior art keywords
diagnostics
diabetic nephropathy
introduction
urine
nephrology
Prior art date
Application number
UA2000031447A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Олег Володимирович Синяченко
Олег Владимирович Синяченко
Валерій Миколайович Казаков
Валерий Николаевич Казаков
Маргарита Валеріївна Зябліцева
Маргарита Валериевна Зяблицева
Ігор Віталійович Мухін
Игорь Витальевич Мухин
Ірина Миколаївна Левада
Ирина Николаевна Левада
Original Assignee
Донецький Державний Медичний Університет Ім. М. Горького
Донецкий Государственный Медицинский Университет Им. М. Горького
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Донецький Державний Медичний Університет Ім. М. Горького, Донецкий Государственный Медицинский Университет Им. М. Горького filed Critical Донецький Державний Медичний Університет Ім. М. Горького
Priority to UA2000031447A priority Critical patent/UA37043A/en
Publication of UA37043A publication Critical patent/UA37043A/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention relates to medicine, in particular to endocrinology and nephrology and can be used for early diagnostics of kidney affection at insular diabetes. Method for diagnostics of diabetic nephropathy includes investigation of morning portion of urine. Additionally with intra-vein drop introduction one introduces 200 m of dopamine with determination of surface tension of urine before and after 3 hours after introduction of preparation with calculation of ratio of results obtained and at decrease of characteristic by 5 % and more compared to initial one, one states diabetic nephropathy.
UA2000031447A 2000-03-14 2000-03-14 Method for diagnostics of diabetic nephropathy UA37043A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA2000031447A UA37043A (en) 2000-03-14 2000-03-14 Method for diagnostics of diabetic nephropathy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA2000031447A UA37043A (en) 2000-03-14 2000-03-14 Method for diagnostics of diabetic nephropathy

Publications (1)

Publication Number Publication Date
UA37043A true UA37043A (en) 2001-04-16

Family

ID=74182783

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2000031447A UA37043A (en) 2000-03-14 2000-03-14 Method for diagnostics of diabetic nephropathy

Country Status (1)

Country Link
UA (1) UA37043A (en)

Similar Documents

Publication Publication Date Title
AU2002902A (en) Method for differentiating irritable bowel syndrome from inflammatory bowel disease (ibd) and for monitoring persons with ibd using total endogenous lactoferrinas a marker
EP2336351A3 (en) Method of selectively determining glycated hemoglobin
CA2351796A1 (en) Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
EP1710568A3 (en) Method of measuring NOx concentration in a gas
CA2055430A1 (en) Glycosylated Haemoglobin Assay
HUP9904042A2 (en) A method of assessing risk for cardiovascular disease and other disorders and phytosterol-based compositions useful in preventing and treating cardiovascular disease and other disorders
EP1211512A3 (en) Test strip for determining dialysate composition
WO2003016906A1 (en) Method of diagnosing or monitoring saccharometabolic error
WO2004096196A3 (en) Treatment of incontinence with 5htc2 agonists
EP0966957A3 (en) In vivo stain composition, process of manufacture, and methods of use to identify dysplastic tissue
UA37043A (en) Method for diagnostics of diabetic nephropathy
WO2006093505A3 (en) Compositions and methods for analyte detection
WO2005033330A3 (en) Fluorescent probes for use in protein kinase inhibitor binding assay
EP2249163A3 (en) Method of pretreating sample for measurement of glycated amine
EP1437591A4 (en) Kits for diagnosing kidney diseases
CA2407760A1 (en) Methods for diagnosis of low grade astrocytoma
WO2005011612A3 (en) Alpha 4 beta 2 delta gaba-a receptors as a strategy for pms and alcoholism
EP1693463A4 (en) Method of measuring saccharified amine
WO2002059600A3 (en) Analyte detection
Menek et al. Analysis of triethanolamine in white cement pastes by voltammetric methods
EP1340821A3 (en) Method of detecting a variant of gh1 as indicator of growth hormone dysfunction
WO2001086288A3 (en) Early diagnosis of bladder tumor in urine samples
EP1387168A3 (en) Physiologically active substance-measuring reagent and method for measuring physiologically active substance
LI et al. Disintegration Effect of Saturated Red Clay under the Action of (NH4) 2CO3
WO2002010772A1 (en) Method of analyzing accumulated fat content in adipocytes